We firmly believe in a science-backed, empathetic, and transparent approach to health
Wahidin Sudirohusodo Hospital in Makassar, Indonesia
Prinz PN, Roehrs TA, Vitaliano PP, et al
(US Institute of Medicine, 1994)
IV administration in wellness clinics operates in an enforcement gray zone the FDA has addressed through warning letters but has not systematically shut down
Tirzepatide even takes it a step further by also mimicking another gut hormone called GIP (Glucose-dependent Insulinotropic Polypeptide), creating a dual-action effect that has shown even greater efficacy for both blood sugar control and weight loss in clinical trials